Print

Ironwood Pharmaceuticals Expects $272 Million In IPO Planned Wednesday  
1/29/2010 6:52:32 AM

Bookmark and Share

NEW YORK (AP) -- Ironwood Pharmaceuticals Inc. plans on raising about $272.4 million through an initial public offering and said it will use the proceeds to develop a drug for irritable bowel syndrome.

//-->